Lam Research (LRCX) director gets 1,635 shares at $0 grant
Lam Research (LRCX): A company director reported an equity grant on a Form 4.
Rhea-AI Filing Summary
Lam Research (LRCX): A company director reported an equity grant on a Form 4. On 11/07/2025, the director acquired 1,635 shares of common stock at $0, typically reflecting a stock or restricted stock unit award. Following this transaction, the director beneficially owned 191,375 shares.
The reported total includes shares subject to unvested restricted stock units, and the ownership is listed as direct.
Positive
- None.
Negative
- None.
Insider Trade Summary
Grant/Award: 1,635 shares
Grant/Award
1 txn
Insider
CANNON MICHAEL R
Role
Director
| Type | Security | Shares | Price | Value |
|---|---|---|---|---|
| Grant/Award | Common Stock | 1,635 | $0.00 | $0.00 |
Holdings After Transaction:
Common Stock — 191,375 shares (Direct)
Footnotes (1)
- F1. The amount reported includes shares subject to unvested restricted stock units.
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
What did Lam Research (LRCX) disclose in this Form 4?
A director acquired 1,635 shares of common stock at $0 on 11/07/2025 as part of an equity grant.
Does the ownership total include unvested RSUs for Lam Research (LRCX)?
Yes. The total includes shares subject to unvested restricted stock units.
What was the transaction price in the Lam Research (LRCX) Form 4?
The reported acquisition price was $0, consistent with a grant.
What was the role of the reporting person at Lam Research (LRCX)?
The individual is reported as a Director.
AI-generated analysis. How Rhea-AI works. Not financial advice.